Literature DB >> 7616456

Association between proliferative verrucous leukoplakia and infection with human papillomavirus type 16.

J M Palefsky1, S Silverman, M Abdel-Salaam, T E Daniels, J S Greenspan.   

Abstract

Proliferative verrucous leukoplakia (PVL) is a recently described clinical entity characterized by multifocal oral lesions that frequently progress to oral cancer despite abstinence from tobacco use by most patients. To determine if this condition is associated with human papillomavirus (HPV), a polymerase chain reaction (PCR) for HPV DNA was performed on 9 lesions from 7 patients with PVL, histologically diagnosed with focal keratosis (1), papilloma (1), epithelial dysplasia (5) and squamous cell cancer (2). Eight (89%) were HPV positive, 7 for HPV 16. For comparison, we studied 55 non-PVL-associated oral specimens, including 24 oral squamous cell cancers. Of the cancers, 8 (33%) were HPV positive, 4 for HPV 16. These data suggest that HPV 16 infection may play an important role in the pathogenesis of PVL-associated oral dysplasia and possibly cancer, but is found in only a small proportion of the more common, non-PVL associated-oral lesions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7616456     DOI: 10.1111/j.1600-0714.1995.tb01165.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  19 in total

Review 1.  Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis, 1985-2010.

Authors:  Vijayvel Jayaprakash; Mary Reid; Elizabeth Hatton; Mihai Merzianu; Nestor Rigual; James Marshall; Steve Gill; Jennifer Frustino; Gregory Wilding; Thom Loree; Saurin Popat; Maureen Sullivan
Journal:  Oral Oncol       Date:  2011-08-03       Impact factor: 5.337

2.  A Retrospective 20-Year Analysis of Proliferative Verrucous Leukoplakia and Its Progression to Malignancy and Association with High-risk Human Papillomavirus.

Authors:  Jasbir D Upadhyaya; Sarah G Fitzpatrick; Mohammed N Islam; Indraneel Bhattacharyya; Donald M Cohen
Journal:  Head Neck Pathol       Date:  2018-02-09

3.  Case report of rapidly progressive proliferative verrucous leukoplakia and a proposal for aetiology in mainland China.

Authors:  Lin Ge; Yun Wu; Lan-yan Wu; Lin Zhang; Bing Xie; Xin Zeng; Mei Lin; Hong-mei Zhou
Journal:  World J Surg Oncol       Date:  2011-02-27       Impact factor: 2.754

Review 4.  Oral premalignant lesions: from a clinical perspective.

Authors:  Teruo Amagasa; Masashi Yamashiro; Narikazu Uzawa
Journal:  Int J Clin Oncol       Date:  2011-01-12       Impact factor: 3.402

Review 5.  Oral leukoplakia and proliferative verrucous leukoplakia: a review for dental practitioners.

Authors:  K Staines; H Rogers
Journal:  Br Dent J       Date:  2017-11-03       Impact factor: 1.626

6.  Human papillomavirus-specific antibody status in oral fluids modestly reflects serum status in human immunodeficiency virus-positive individuals.

Authors:  Jennifer E Cameron; Isaac V Snowhite; Anil K Chaturvedi; Michael E Hagensee
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

7.  Salivary and serum interleukin-6 levels in proliferative verrucous leukoplakia.

Authors:  Leticia Bagan; Guillermo T Sáez; M Carmen Tormos; Carlos Labaig-Rueda; Judith Murillo-Cortes; Jose V Bagan
Journal:  Clin Oral Investig       Date:  2015-08-09       Impact factor: 3.573

8.  Immune expression profile identification in a group of proliferative verrucous leukoplakia patients: a pre-cancer niche for oral squamous cell carcinoma development.

Authors:  Carlos Llorens; Beatriz Soriano; Lucia Trilla-Fuertes; Leticia Bagan; Ricardo Ramos-Ruiz; Angelo Gamez-Pozo; Cristina Peña; Jose V Bagan
Journal:  Clin Oral Investig       Date:  2020-09-11       Impact factor: 3.573

9.  [Proliferative verrucous leukoplakia. Report of five cases].

Authors:  P A Reichart; H P Philipsen
Journal:  Mund Kiefer Gesichtschir       Date:  2003-05-01

10.  Epithelial maturation and molecular biology of oral HPV.

Authors:  Liviu Feller; Razia Ag Khammissa; Neil H Wood; Johan Lemmer
Journal:  Infect Agent Cancer       Date:  2009-11-25       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.